Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Schuster

Showing results (241-250 of 253) with videos related to

Pageof 26
Sort By:
The Journal of Urology|June 25, 2013
Practice based collaboration to improve the use of immediate intravesical therapy after resection of nonmuscle invasive bladder cancerDaniel A Barocas, Alice Liu, Frank N Burks, et al.
The Journal of Infectious Diseases|September 9, 1999
Randomized dose-ranging study of the safety and efficacy of WR 238605 (Tafenoquine) in the prevention of relapse of Plasmodium vivax malaria in ThailandD S Walsh, S Looareesuwan, P Wilairatana, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 2010
A single TCR alpha-chain with dominant peptide recognition in the allorestricted HER2/neu-specific T cell repertoireXiaoling Liang, Luise U Weigand, Ingrid G Schuster, et al.
Medical Mycology|June 12, 2012
Antifungal therapy and length of hospitalization in transplant patients with invasive aspergillosisJohn W Baddley, David R Andes, Kieren A Marr, et al.
Medical Mycology|April 25, 2015
Phaeohyphomycosis in transplant recipients: Results from the Transplant Associated Infection Surveillance Network (TRANSNET)Todd P McCarty, John W Baddley, Thomas J Walsh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 11, 2010
Factors associated with mortality in transplant patients with invasive aspergillosisJohn W Baddley, David R Andes, Kieren A Marr, et al.
American Journal of Hematology|April 4, 2020
Risk of invasive fungal infections in patients with high-risk MDS and AML receiving hypomethylating agentsGee Youn Geeny Kim, Jonathan Burns, Craig W Freyer, et al.
Open Forum Infectious Diseases|March 14, 2024
Modeling Invasive Aspergillosis Risk for the Application of Prophylaxis StrategiesJo-Anne H Young, David R Andes, Monica I Ardura, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 27, 2015
Infections after Transplantation of Bone Marrow or Peripheral Blood Stem Cells from Unrelated DonorsJo-Anne H Young, Brent R Logan, Juan Wu, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 5, 2014
Endemic fungal infections in solid organ and hematopoietic cell transplant recipients enrolled in the Transplant-Associated Infection Surveillance Network (TRANSNET)C A Kauffman, A G Freifeld, D R Andes, et al.
Pageof 26

Showing results (241-250 of 253) with videos related to

Sort By:
Pageof 26
The Journal of Urology|June 25, 2013
Practice based collaboration to improve the use of immediate intravesical therapy after resection of nonmuscle invasive bladder cancerDaniel A Barocas, Alice Liu, Frank N Burks, et al.
The Journal of Infectious Diseases|September 9, 1999
Randomized dose-ranging study of the safety and efficacy of WR 238605 (Tafenoquine) in the prevention of relapse of Plasmodium vivax malaria in ThailandD S Walsh, S Looareesuwan, P Wilairatana, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 2010
A single TCR alpha-chain with dominant peptide recognition in the allorestricted HER2/neu-specific T cell repertoireXiaoling Liang, Luise U Weigand, Ingrid G Schuster, et al.
Medical Mycology|June 12, 2012
Antifungal therapy and length of hospitalization in transplant patients with invasive aspergillosisJohn W Baddley, David R Andes, Kieren A Marr, et al.
Medical Mycology|April 25, 2015
Phaeohyphomycosis in transplant recipients: Results from the Transplant Associated Infection Surveillance Network (TRANSNET)Todd P McCarty, John W Baddley, Thomas J Walsh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 11, 2010
Factors associated with mortality in transplant patients with invasive aspergillosisJohn W Baddley, David R Andes, Kieren A Marr, et al.
American Journal of Hematology|April 4, 2020
Risk of invasive fungal infections in patients with high-risk MDS and AML receiving hypomethylating agentsGee Youn Geeny Kim, Jonathan Burns, Craig W Freyer, et al.
Open Forum Infectious Diseases|March 14, 2024
Modeling Invasive Aspergillosis Risk for the Application of Prophylaxis StrategiesJo-Anne H Young, David R Andes, Monica I Ardura, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 27, 2015
Infections after Transplantation of Bone Marrow or Peripheral Blood Stem Cells from Unrelated DonorsJo-Anne H Young, Brent R Logan, Juan Wu, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 5, 2014
Endemic fungal infections in solid organ and hematopoietic cell transplant recipients enrolled in the Transplant-Associated Infection Surveillance Network (TRANSNET)C A Kauffman, A G Freifeld, D R Andes, et al.
Pageof 26